(19)
(11) EP 1 231 939 A2

(12)

(88) Date of publication A3:
21.03.2002

(43) Date of publication:
21.08.2002 Bulletin 2002/34

(21) Application number: 00983695.8

(22) Date of filing: 09.11.2000
(51) International Patent Classification (IPC)7A61K 45/06, A61P 35/00
(86) International application number:
PCT/US0030/944
(87) International publication number:
WO 0103/4135 (17.05.2001 Gazette 2001/20)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.11.1999 US 164713 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • FLEISCH, Jerome, Herbert
    Carmel, IN 46032 (US)
  • SAWYER, Jason, Scott
    Indianapolis, IN 46220 (US)
  • TEICHER, Beverly, Ann
    Carmel, IN 46033 (US)
  • BEIGHT, Douglas, Wade
    Frankfort, IN 46041 (US)
  • SMITH, Edward, C., R.
    Fishers, IN 46038 (US)
  • MCMILLEN, William, Thomas
    Fishers, IN 46038 (US)

(74) Representative: Burnside, Ivan John et al
Eli Lilly and Company LimitedLilly Research CentreErl Wood ManorSunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER